QNRX
FDA Grants QUOIN PHARMACEUTICALS Second Rare Pediatric Tag for QRX003
Quoin's lead asset QRX003 receives Rare Pediatric Disease Designation for Peeling Skin Syndrome, opening the door to a second Priority Review Voucher.
QNRX
Market-moving news on Quoin Pharmaceuticals (NASDAQ: QNRX): filings, earnings, deals and other events, from REDFILED.